Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/nep.13602 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
KHA-CARI commentary on the KDIGO clinical practice guideline on the evaluation and care of living kidney donors.
Nephrology (Carlton)
January 2020
Department of Nephrology, Monash Health and Centre for Inflammatory Diseases, Melbourne, Victoria, Australia.
KHA-CARI commentary on the KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease.
Nephrology (Carlton)
November 2014
Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand; Cochrane Renal Group, Sydney, Australia.
Optimal targets for blood pressure control in chronic kidney disease: the debate continues.
Curr Opin Nephrol Hypertens
November 2014
aThe George Institute for Global Health bSydney Medical School, University of Sydney cRoyal North Shore Hospital, Sydney, New South Wales, Australia.
Purpose Of Review: Because advanced chronic kidney disease (CKD) is often an exclusion criterion for large randomized trials of the management of hypertension, clinical decision making for these patients has relied on a few small, specific studies and much extrapolation. Several blood pressure treatment guidelines have recently been reissued. This review explores the applicability of the revised recommendations to CKD.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!